Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risedronate for Prevention of Osteoporosis After Spinal Cord Injury

NCT00150696 is registered in ClinicalTrials.gov with Toronto Rehabilitation Institute as lead sponsor.

NCT NCT00150696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risedronate for Prevention of Osteoporosis After Spinal Cord Injury
Lead sponsor
Toronto Rehabilitation Institute
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2000
Completion date
November 30, 2005
Enrollment
38
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute spinal cord injury.